From this paper Altmann et al. 2023 The immunology of long COVID https://www.nature.com/articles/s41577-023-00904-7 https://www.s4me.info/threads/the-immunology-of-long-covid-2023-altmann-et-al.34116/ https://twitter.com/user/status/1679144090410315776
Immunoadsorption vs. Sham Treatment in Post COVID Patients With Chronic Fatigue Syndrome https://classic.clinicaltrials.gov/ct2/show/NCT05954325?cond=ME/CFS&cntry=DE&sfpd_s=07/06/2023&sfpd_d=14&sel_rss=new14
https://twitter.com/user/status/1697962998797631761 Dr. Scheibenbogen’s group at the Charité in Berlin has published interim results of a small open label study of repeat immunoadsorption (depletes immunoglobulin levels through apheresis). Of 10 post-Covid ME/CFS patients with elevated ß2-adrenergic AAbs, 7 responded to treatment
Apheresis being the treatment where they pull your blood, take out what they don't like and put it back in again right?
Reduces volume load to heart by increasing glucose removed via kidneys/urine (diuretic effect). Classified as Type II diabetes med. https://www.drugs.com/dapagliflozin.html or my best amateur guess...